Toronto Dominion Bank Has $6.46 Million Holdings in Clorox Company (The) (CLX)

Toronto Dominion Bank grew its stake in Clorox Company (The) (NYSE:CLX) by 12.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 48,946 shares of the company’s stock after acquiring an additional 5,319 shares during the quarter. Toronto Dominion Bank’s holdings in Clorox Company (The) were worth $6,455,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in CLX. Janus Henderson Group PLC boosted its holdings in Clorox Company (The) by 8,008.5% in the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock worth $176,340,000 after acquiring an additional 1,307,153 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Clorox Company (The) by 2.6% in the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock worth $1,936,595,000 after acquiring an additional 369,918 shares in the last quarter. APG Asset Management N.V. boosted its holdings in Clorox Company (The) by 30.9% in the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock worth $171,736,000 after acquiring an additional 307,700 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in Clorox Company (The) by 24.6% in the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock worth $178,433,000 after acquiring an additional 265,200 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in Clorox Company (The) by 24.5% in the second quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock worth $178,728,000 after acquiring an additional 263,700 shares in the last quarter. 71.58% of the stock is currently owned by institutional investors and hedge funds.

Shares of Clorox Company (CLX) opened at $133.51 on Friday. The company has a market capitalization of $17,080.00, a price-to-earnings ratio of 24.38, a P/E/G ratio of 3.69 and a beta of 0.39. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. Clorox Company has a 1 year low of $112.28 and a 1 year high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. Clorox Company (The)’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.36 earnings per share. equities analysts forecast that Clorox Company will post 5.58 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox Company (The)’s dividend payout ratio (DPR) is presently 61.65%.

Several equities research analysts have commented on the company. Jefferies Group LLC reissued a “hold” rating and issued a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Barclays PLC restated an “equal weight” rating and issued a $136.00 price target (down previously from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $128.72.

In related news, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now owns 20,614 shares in the company, valued at $2,862,666.18. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. In the last quarter, insiders have sold 41,293 shares of company stock valued at $5,560,303. 1.00% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: “Toronto Dominion Bank Has $6.46 Million Holdings in Clorox Company (The) (CLX)” was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://ledgergazette.com/2017/11/18/toronto-dominion-bank-has-6-46-million-holdings-in-clorox-company-the-clx.html.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply